2m 2m 2m 2m 2m 2m 2m
Alnylam Pharma (ALNY)
NASDAQ
$218.44-$0.76 (-0.35%)
Price as of Aug 07, 2026 7:57 PM EDT- $29.3BMarket Cap
- -50.06%1-Year Change
- BiotechnologyIndustry
Alnylam Pharma (ALNY)
$218.44-$0.76 (-0.35%)
ALNY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $219.20 | ||
Change | +$3.08 (+1.43%) | ||
Open | $217.31 | ||
High | $219.64 | ||
Low | $210.49 | ||
Previous Close | $216.12 | ||
Volume | 1,735,952 | ||
30-Day Average Volume | 2,376,312 | ||
1-Week Change | 6.66% | ||
1-Month Change | -31.84% | ||
1-Year Change | -50.06% | ||
3-Year Change | 18.94% | ||
5-Year Change | 12.28% | ||
Fundamentals | |||
Shares Outstanding | 133.8M | ||
Total Assets | $5.6B | ||
Market Cap | $29.3B | ||
Enterprise Value | $28.6B | ||
Period: QTR TTM FY | |||
Revenue | $1.2B | ||
Net Income | $164.5M | ||
Free Cash Flow | $292.0M | ||
EBIT | $177.8M | ||
EBITDA | $191.7M | ||
Net Working Capital | $3.1B | ||
EPS | $1.21 | ||
Enterprise Value/EBITDA | 149 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 22 | ||
P/E | 181 | ||
PEG | -9 | ||
Price/Free Cash Flow | 100 | ||
Price/Operating Cash Flow | 90 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue